1991: Plans for the Cochrane Schizophrenia Group (CSzG) began when Iain Chalmers, Muir Gray and others supported Clive Adams' efforts to investigate the formation of the group by publishing papers and testing the enthusiasm for the idea amongst colleagues.
1993: Clive had gathered sufficient support within the subspeciality, and was mandated to establish a Cochrane Group which focused on the care of people with schizophrenia.
1994: By April it was possible to apply for the registration of the Schizophrenia Group with the Cochrane Collaboration. A small but crucial grant from the Mental Health Foundation allowed an administrator to be employed, and the first systematic review was produced shortly afterwards. The contributions of Dr Jeremy Anderson and Professor Jair Mari (two of the founding editors) and Rachel Lee and Rochelle Seifas (Managing Editors) were invaluable in the early days of the group.
The Group's Register of Trials was also instigated in 1994 with the help of a small grant from the Oxford Regional Health Authority. This important painstaking groundwork was supported by Iain Chalmers, Michael Gelder, Muir Gray, a number of local medical students and considerable goodwill on the part of the library staff of the Warneford Hospital in Oxford, especially Doreen Ledgard.
Present day: The current work of the CSzG is co-ordinated by the members of the Editorial Base team.
Funding the Cochrane Schizophrenia Group
The CSzG is part of the international Cochrane Collaboration, an independent not-for-profit cosortium dedicated to providing up-to-date, accurate information about the effects of health care. The work of the CSzG Editorial Base team is largely funded by the National Institute for Health Research (NIHR), with additional support from the University of Nottingham. Funding is also obtained from the delivery of the Nottingham Systematic Review Course, which contributes to the cost of providing administration support. The CSzG also gratefully acknowledges a small, anonymous donation received in 2005 to promote the provision of systematic reviews in China. The CSzG does not seek any funding from industry.
Image licenced for use under the Creative Commons licence, courtesy of: Maja Dumat., Mark Seton and Wikipedia.